Johnson & Johnson (NYSE: JNJ) beats Q3-FY2026-EPS consensus estimate of $2.66 — earnings report October 13, 2026 before market open (confirmed by JNJ Investor Relations or Bloomberg by October 13, 2026)
Pending
✦ AI-generated prediction
Published on 12. October 2026
·
Predicted for 13. October 2026
·
Based on: Historical Cycle
Johnson & Johnson reports Q3-FY2026 earnings on October 13, 2026 before market open. Analyst consensus EPS stands at $2.66 (MarketBeat, October 12, 2026). J&J has beaten consensus EPS estimates in approximately 75-80% of recent quarters. The Innovative Medicine segment (oncology, immunology) and stable MedTech demand support another beat. No specific Polymarket or Metaculus market found; probability conservatively derived from historical beat rate.
Data basis for this prediction
- MarketBeat: JNJ Q3-FY2026 EPS-Konsens 2,66 USD (Stand 12.10.2026)
- J&J historische EPS-Beat-Rate ~75–80 % (letzte 20 Quartale, Macrotrends/MarketBeat)
- JNJ Investor Relations: Ergebnistermin 13.10.2026 vor 8:30 Uhr ET
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
Citigroup reports Q3-FY2026 results on October 13, 2026, pre-market open. General consensus: ~$2.65 EPS (Pluang/market majority), Alphastreet estimate: $2.62. Benzinga anticipates higher year-over-year earnings. The 90-day estimate stood at $2.69 — the modest downward drift suggests conservative analyst positioning, which increases the probability of a positive surprise. Large US banks historically beat EPS consensus in ~65% of quarters. The $2.65 threshold corresponds to the upper end of the consensus range.
📈 Economy
✦ AI
The Nikkei 225 is trading at ~69,170 points on October 12, 2026 (+43.5% YoY, 52-week high: 72,832). A threshold of 71,000 requires a further gain of ~+2.6% over the remaining ~11 weeks of the year. Analyst consensus (QUICK survey, 114 firms): year-end median 71,704 points; Nomura base case 70,000; BofA (most bearish outlier) 61,000. Drivers: 19.2% TOPIX earnings growth forecast for FY2026 (Nomura), structural capital inflows into Japanese equities (Buffett effect), BoJ terminal rate expectation ~1.1% — anchored, no shock expected. The 71,000 threshold sits just below the analyst consensus median and is therefore rated as achievable by slightly more than half of polled houses.
📈 Economy
✦ AI
The US Federal Reserve last raised rates on September 16, 2026 by 25 basis points to 3.75%-4.00%. CME FedWatch data (rateprobability.com, October 12, 2026) shows only ~16-18% probability of another hike at the October 28 meeting; ~82-84% for an unchanged hold. Weak September payrolls and mixed inflation data have shifted the consensus timing for the next hike to the December 9, 2026 meeting, where markets price ~76% probability of a move. No specific Polymarket market found for the October meeting; anchor: CME FedWatch ~84% Hold.